Insights

Strategic partnerships Genprex collaborates with leading institutions and Roche Diagnostics to validate biomarkers and enhance patient selection in NSCLC trials, presenting an opportunity to offer co-development, diagnostics integration, and companion diagnostic services for targeted therapies.

Expansion potential Requests for scale-up manufacturing and IND-enabling work for AAV-based diabetes gene therapy indicate demand for contract development and manufacturing (CDMO) support, especially in cGMP processes and process optimization.

Clinical focus A strong oncology program with Fast Track Designations for NSCLC programs and ongoing DIABETES candidates suggests opportunities to provide regulatory consulting, patient stratification tools, and trial-enabling services to accelerate clinic timelines.

Manufacturing needs Recent client onboarding by Andelyn Biosciences for diabetes gene therapy manufacturing signals potential service engagements in upstream/downstream manufacturing, process optimization, and scale-up for viral vector products.

Biomarker opportunities Roche collaboration on TROP2 biomarker validation for patient selection opens doors for biomarker assay development, companion diagnostics partnerships, and data analytics services to improve trial design and enrichment strategies.

Genprex, Inc. Tech Stack

Genprex, Inc. uses 8 technology products and services including Drupal, WordPress, SAP, and more. Explore Genprex, Inc.'s tech stack below.

Drupal

Content Management System

WordPress

Content Management System

SAP

Customer Relationship Management

Adobe Experience Cloud

Data Management Platforms

E-commerce

E-commerce

Real User Monitoring

Genprex, Inc. Email Formats	Example	Percentage
FLast@genprex.com	JDoe@genprex.com	97%
LastF@genprex.com	DoeJ@genprex.com	3%

Genprex, Inc. Email Formats

Example

Percentage

FLast@genprex.com

JDoe@genprex.com

97%

LastF@genprex.com

DoeJ@genprex.com

Frequently Asked Questions

What is Genprex, Inc.'s phone number?

You can contact Genprex, Inc.'s main corporate office by phone at

+1-512-370-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Genprex, Inc.'s official website and social media links?

Genprex, Inc.'s official website is genprex.com and has social profiles on LinkedIn.

How much revenue does Genprex, Inc. generate?

As of October 2026, Genprex, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Genprex, Inc.'s SIC code and NAICS code?

Genprex, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Genprex, Inc. have currently?

As of October 2026, Genprex, Inc. has approximately 23 employees across 2 continents, including North America and Asia. Key team members include Chairman, Chief Executive Officer: R. R., Corporate Controller: G. J. and Independent Director: W. W. Explore Genprex, Inc.'s employee directory with LeadIQ.

What industry does Genprex, Inc. belong to?

Genprex, Inc. operates in the Biotechnology Research industry.

What technology does Genprex, Inc. use?

Genprex, Inc.'s tech stack includes Drupal, WordPress, SAP, Adobe Experience Cloud, NetSuite, Shopify, Microsoft 365 and New Relic.

What is Genprex, Inc.'s email format?

Genprex, Inc.'s email format typically follows the pattern of FLast@genprex.com. Find more Genprex, Inc. email formats with LeadIQ.

When was Genprex, Inc. founded?

Genprex, Inc. was founded in 2009.

Genprex, Inc.

Q: What is Genprex, Inc.'s official website and social media links?

Genprex, Inc.'s official website is genprex.com. Genprex, Inc. has social profiles on LinkedIn.

Q: How many employees does Genprex, Inc. have currently?

Genprex, Inc. has approximately 23 employees.

Q: What technology does Genprex, Inc. use?

Genprex, Inc.'s tech stack includes Google Tag Manager, particles.js, Microsoft Project, WordPress Block Editor, Really Simple Discovery.

Q: What is Genprex, Inc.'s NAICS code?

Genprex, Inc.'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchTexas, United States11-50 Employees

Genprex, Inc. is a clinical-stage biotechnology company based in Austin, Texas, focused on developing gene therapies for cancer and diabetes. It seeks to deliver disease-fighting genes through a proprietary, non-viral delivery system designed for systemic administration, aiming to reach patient populations with limited treatment options. Its oncology program centers on REQORSA for non-small cell lung cancer and small cell lung cancer, currently evaluated in multiple clinical trials with FDA Fast Track designations, and the company partners with academic and research institutions to advance its pipeline. 

In diabetes, Genprex pursues a gene-therapy approach that delivers Pdx1 and MafA to the pancreas via an endoscopic infusion, with GPX-002 and GPX-003 targeted at Type 1 and Type 2 diabetes, respectively. Recent activity includes participation in BIO Europe Spring 2026 and a collaboration with ALK Positive to advance preclinical studies.

Insights

Similar companies to Genprex, Inc.

CEL-SCI Corporation

GasLog Ltd.

Mustang Bio

Genprex, Inc. Tech Stack

Media & News

Genprex, Inc. is scheduled to present at and participate in the H.C. Wainwright 28th Annual Global Investment Conference from Sep 14th to Sep 16th '26 in New York, highlighting its lead clinical oncology and preclinical diabetes programs.

Genprex, Inc. is developing Oncoprex immunogene therapy, which is being evaluated in clinical trials across the United States to restore tumor suppressor function and enhance responses to existing targeted therapies in patients with non-small cell lung cancer.

Andelyn Biosciences, Inc. signs Genprex, Inc. as a new client after Genprex, Inc. selects it to support scale-up manufacturing, process optimization, and IND-enabling and clinical-stage cGMP manufacturing for its AAV-based diabetes gene therapy candidate in Ohio on Sep 1st '26.

Andelyn Biosciences, Inc. signs Genprex, Inc. as a new client to support scale-up manufacturing for its diabetes gene therapy program in Ohio on Sep 1st '26, including process optimization, scale-up, IND-enabling, and clinical-stage cGMP manufacturing.

Genprex, Inc. and Roche Diagnostics begin TROP2 antibody assay validation to support biomarker-guided REQORSA development in NSCLC, with Roche Diagnostics validating the assay for possible patient selection in clinical studies and Genprex, Inc. targeting completion around year-end 2026.

Genprex, Inc. partners with Roche to validate biomarkers for patient selection in non-small cell lung cancer clinical trials and refine patient identification using TROP2 in Texas on Aug 3rd '26.

On Aug. 3rd '26, Genprex, Inc. collaborates with Roche Diagnostics to validate biomarkers, including TROP2, for patient selection in non-small cell lung cancer clinical trials in Texas.

Genprex, Inc.'s Email Address Formats